TG Therapeutics: 2025 Revenues Will Smash Expectations

TG Therapeutics (NASDAQ: TGTX ) is a biotech company focused on Briumvi, a treatment for Multiple Sclerosis. I will not go into great detail on the unique mechanisms of this drug, as this is not myLike millions of other investors, I got Robinhood and started trading during the pandemic. Unlike most of those investors, I carefully studied hundreds of earnings reports for clues to future performance, and I was able to identify many future winners, such as OPRX, OTRK, FUBO, and PLUG. My style of investing is i ...